Summary
Amoneta aims to raise the awareness, acceptance and support of the scientific and medical experts regarding the novel IVD assay for AD diagnosis:
Outcomes from the ADDIA project will be presented at international and national conferences.
Regular updates (in the form of abstracts, presentations, posters) regarding the progress of the project and the preliminary results will be provided to all relevant scientific organisations at European and international level.
Scientific articles of the findings of the clinical trial will be published in (open access) peer reviewed scientific and medical journals.
More information & hyperlinks